Chromothripsis is a newly discovered mutational phenomenon involving massive, clustered genomic rearrangements that occurs in cancer and other diseases. Recent studies in cancer suggest that chromothripsis may be far more common than initially inferred from low resolution DNA copy number data. Here, we analyze the patterns of chromothripsis across 2,658 tumors spanning 39 cancer types using whole-genome sequencing data. We find that chromothripsis events are pervasive across cancers, with a frequency of >50% in several cancer types. Whereas canonical chromothripsis profiles display oscillations between two copy number states, a considerable fraction of the events involves multiple chromosomes as well as additional structural alterations. In addition to non-homologous end-joining, we detect signatures of replicative processes and templated insertions. Chromothripsis contributes to oncogene amplification as well as to inactivation of genes such as mismatch-repair related genes. These findings show that chromothripsis is a major process driving genome evolution in human cancer.
Summary
Chromothripsis is a newly discovered mutational phenomenon involving massive, clustered genomic rearrangements that occurs in cancer and other diseases. Recent studies in cancer suggest that chromothripsis may be far more common than initially inferred from low resolution DNA copy number data. Here, we analyze the patterns of chromothripsis across 2,658 tumors spanning 39 cancer types using whole-genome sequencing data. We find that chromothripsis events are pervasive across cancers, with a frequency of >50% in several cancer types. Whereas canonical chromothripsis profiles display oscillations between two copy number states, a considerable fraction of the events involves multiple chromosomes as well as additional structural alterations. In addition to non-homologous end-joining, we detect signatures of replicative processes and templated insertions. Chromothripsis contributes to oncogene amplification as well as to inactivation of genes such as mismatch-repair related genes. These findings show that chromothripsis is a major process driving genome evolution in human cancer.
INTRODUCTION
Chromothripsis is a mutational phenomenon characterized by massive genomic rearrangements, often generated in a single catastrophic event and localized to isolated chromosomal regions [1] [2] [3] [4] . In contrast to the traditional view of tumorigenesis as a gradual Darwinian process of progressive mutation accumulation, chromothripsis provides a mechanism for the rapid accrual of hundreds of rearrangements in few cell divisions.
This phenomenon has been studied in primary tumors of diverse histological origin [5] [6] [7] [8] [9] [10] , but similar random joining of chromosomal fragments has also been observed in the germline 11 . There has been considerable progress in elucidating the mechanism by which chromothripsis may arise, including fragmentation and subsequent reassembly of a single chromatid in aberrant nuclear structures called micronuclei 2, 12 , as well as fragmentation of dicentric chromosomes in telomere crisis 13, 14 . Chromothripsis is not specific to cancer, as it can cause rare congenital human disease and can be transmitted through the germline 11, 15 ; it has also been described in plants, where it has been linked to micronucleation 16 . However, despite the recent rapid progress on chromothripsis, much remains to be discovered regarding its cause, prevalence, and consequences.
A hallmark of chromothripsis is multiple oscillations between two or three copy number (CN) states 1, 6 . Applying this criterion to copy number profiles inferred from SNP arrays, chromothripsis was initially estimated to occur in at least 2-3% of human cancers and in ~25% of bone cancers 1 . Subsequent studies of large array-based datasets gave similar frequencies: 1.5% (124 of 8,227 tumors across 30 cancer types) 17 and 5% (918 out of 18,394 tumors across 132 cancer types) 18 , with the highest frequencies detected for soft-tissue tumors (54% for liposarcomas, 24% for fibrosarcomas, and 23% for sarcomas) 18 . These estimates relied on the detection of copy number oscillations that are more densely clustered than expected by chance, e.g., at least 10 adjacent CN oscillations in medulloblastomas 8 .
Whole-genome sequencing (WGS) data provide a greatly enhanced view of structural variations (SVs) in the genome with breakpoints identified at single nucleotide resolution.
They also provide information on the rearranged DNA sequence, which can be used to determine the type of SVs (e.g., deletion, insertion, inversion) and to infer the likely repair mechanism for joining fragments (e.g., based on the degree of microhomology, or the presence or absence of small insertions at the breakpoints). With higher spatial resolution and additional information provided by WGS data, it is possible to postulate a more nuanced set of criteria for chromothripsis and enhance detection specificity 3 . Our earlier analysis of WGS data from cutaneous melanomas already found chromothripsislike rearrangements in 38% (45 out of 117 patients) 10 ; other studies based on WGS found 60-65% 5 for pancreatic cancer, and 32% for esophageal adenocarcinomas 7 .
Whether these examples are outliers reflecting the unique biology of these tumors, or whether they reflect a more general underestimation of the frequency of chromothripsis remained unclear.
Motivated by the importance of chromothripsis during tumor evolution and the need for more systematic and comprehensive analysis, we sought to determine the frequency and spectrum of chromothripsis events in the WGS data for 2,658 cancer patients spanning 39 cancer types, available through the International Cancer Genome Consortium (ICGC). In addition to deriving more accurate per-tumor type prevalence of chromothripsis, we determine the size and genomic distribution of such events, examine their role in amplification of oncogenes or loss of tumor suppressors, describe their relationship to genome ploidy, and investigate whether their presence is correlated with patient survival. Our chromothripsis calls can be browsed at the accompanying website:
http://compbio.med.harvard.edu/chromothripsis/.
RESULTS

Prevalence of chromothripsis across cancer types
We first sought to formulate a set of criteria for identifying chromothripsis events with varying complexities (Fig. 1a) . The generally acknowledged model of chromothripsis posits that some of the DNA fragments generated by the shattering of the DNA are lost;
thus, copy number oscillations between two or three states 1, 6 are an obvious first criterion (Fig. 1a) . Such deletions also lead to interspersed loss of heterozygosity (LOH), . Therefore, for the discussion below we will refer generally to "chromothripsis" as encompassing both classes of models.
To detect chromothripsis from WGS data, we developed ShatterSeek (a detailed description of the algorithm and its performance is provided in Online Methods and Supplementary Note). A key feature of our method is to identify clusters of breakpoints belonging to SVs that are interleaved, i.e., the regions bridged by their breakpoints overlap instead of being nested ( Fig. 1) , as is expected from random joining of genomic fragments. This encompasses the many cases that do not display simple oscillations, e.g., partially oscillating CN profiles with interspersed amplifications, and oscillations spanning multiple CN levels due to aneuploidy 5, 20 . Rearrangements in chromothripsis should also follow a roughly even distribution for the different types of fragment joins (i.e., duplication-like, deletion-like, head-to-head and tail-to-tail inversions, depicted in blue, orange, black, and green, respectively, in Fig. 1a and throughout the manuscript) and have breakpoints randomly distributed across the affected region [1] [2] [3] . Finally, by criteria to be described below, we also use interchromosomal SVs to identify chromothripsis events involving multiple chromosomes.
After removing low-quality samples using stringent quality control criteria, we applied our chromothripsis detection method to 2,543 tumor-normal pairs spanning 37 cancer types (Supplementary Table 1 and Online Methods). 2,428 cases harbored SVs and were considered for further analysis. To tune the parameters in our method, we used statistical thresholds and visual inspection. For the minimum number of oscillating CN segments, we used two thresholds: 'high-confidence' calls display oscillations between two states in at least 7 adjacent segments, whereas 'low-confidence' calls involve between 4 and 6 segments ( Fig. 1b and Supplementary Note). The analyses described in the following sections were performed using the high-confidence call set unless otherwise stated.
We first focused on the 1,427 nearly-diploid genomes (ploidy ≤ 2.1; Supplementary The frequency of chromothripsis varies markedly across cancer types. At the high end, we find that 100% of liposarcomas (SoftTissue−Liposarc) and 77% of osteosarcomas (Bone−Osteosarc) exhibit high-confidence chromothripsis ( Fig. 1c and Supplementary   Fig. 1 ). Although higher susceptibility of these cancer types to chromothripsis has been described 1, 20 , our estimated frequencies are substantially higher. Ovarian adenocarcinomas (Ovary-AdenoCA), breast adenocarcinomas (Breast-AdenoCA), melanomas (Skin-Melanoma), CNS-GBM, esophageal adenocarcinomas (Eso−AdenoCA), and Lung-AdenoCA showed evidence of chromothripsis in >50% of the cases. If we consider low-confidence calls, the frequencies are generally 20-25% higher for these tumors (Fig. 1c) . In contrast, the frequencies were lowest in thyroid adenocarcinomas (Thy-AdenoCA; 0%, n=30), lymphoid chronic lymphocytic leukemia (Lymph-CLL; 0%, n=86), and pilocytic astrocytomas (CNS-PiloAstro; 0%, n=78); in the other tumor types with low incidence, the sample sizes are too small to give meaningful estimates.
Overall, these results indicate much greater prevalence of chromothripsis in a majority of human cancers than previously estimated 10, 17, 18 . The immense variations we observe across tumor types cannot be explained by random fluctuations and must be linked to tumor biology.
Understanding the difference between our frequency estimates and previous ones
In accordance with some recent analyses that found dramatically higher frequency of chromothripsis in specific tumor types 5, 7 , our overall estimates are considerably higher than those in prior pan-cancer studies. This is in large part due to the fact that previous chromosomes in a micronucleus or in a chromosome bridge) or from fragmentation of a chromosome that had previously undergone a non-reciprocal translocation.
Distinguishing these scenarios requires a case-by-case analysis that is beyond the scope of this study. However, it is likely that both mechanisms contribute to the generation of chromothripsis involving multiple chromosomes.
Size and complexity of chromothripsis events are highly variable
Chromothripsis events span a wide range of genomic scale, with the number of breakpoints involved varying by three orders of magnitude within some tumor types ( Supplementary Fig. 1c ). We find tumors in which relatively focal chromothripsis events, usually a few Mb in size, take place against the backdrop of an otherwise quiet genome (lower-right quadrant in Fig. 2d ). Although focal, these events can lead to the simultaneous amplification of multiple oncogenes located in different chromosomes ( Supplementary Figs. 3c -e, 4a-c). Other focal events co-localize with other complex events in highly rearranged genomes (lower-left quadrant in Fig. 2d ).
Those events spanning large genomic regions comprise tens to hundreds of SVs, affecting anywhere from one chromosome arm to more than 10 chromosomes (Fig. 2a-c ). We observe 47 tumors harboring >200 rearrangements, of which at least 50% belong to chromothripsis regions (upper-right quadrant in Fig. 2d ). Overall, our analysis reveals greater heterogeneity of chromothripsis patterns than previously appreciated, both in terms of the number of SVs and chromosomes involved.
Relationship between chromothripsis and aneuploidy
Newly established polyploid cells have high rates of mitotic errors that generate lagging After correcting for tumor type using the logistic regression, we estimate that the odds of chromothripsis occurring in a polyploidy tumor is 1.5 times larger than that in a diploid tumor on average (1.20-1.85 95% CI; P < 10 -3
, cases with ploidy ≥ 2.5). Although polyploidy is associated with higher incidence of chromothripsis, this may be primarily due to the presence of increased genomic material in polyploids. Polyploidy, on the other hand, could reduce the sensitivity of CNV and SV detection (due to lower sequence coverage per copy), and might make it easier for the cell to lose the highly-rearranged copy when intact copies are present 27 .
Frequent co-localization of chromothripsis with other complex events
About half of the chromothripsis events co-localize with other genomic alterations ( Fig. 1 and Supplementary Fig. 1b ). Such cases are abundant in SoftTissue-Liposarc (74% of the events), Breast-AdenoCA (65%), Bone-Osteosarc (60%), Skin-Melanoma (59%), Eso-AdenoCA (58%), and Ovary-AdenoCA (55%; Supplementary Figs. 1-2). There is evidence across multiple tumor types that chromothripsis might occur prior or after additional layers of rearrangements [6] [7] [8] 13, 14, 28 . For instance, BFB cycles have been postulated to be mechanistically linked to chromothripsis, and telomere attrition, which results in the formation of BFB cycles, has been identified as a predisposing factor for chromothripsis 6, 13, 29 .
Co-localization of APOBEC-mediated kataegis and rearrangements has been reported for multiple cancer types 30, 31 , and has been linked to double-strand break resection 
TP53 mutation status and chromothripsis
Inactivating TP53 mutations have been previously associated with chromothripsis in medulloblastomas 8 and in pediatric cancers 35, 36 . TP53 deficient cells serve as models to generate chromothripsis in vitro 2, 14 . Nevertheless, the relationship between deleterious TP53 mutations and chromothripsis has not been examined comprehensively. In our data, ~38% of the patients with inactivating TP53 mutations show chromothripsis, whereas only 24% of those with wildtype TP53 exhibit chromothripsis ( 
Signatures of repair mechanisms in chromothripsis regions
By examining the sequence homology at the breakpoints, it is possible to infer the predominant mechanisms responsible for the chromothripsis event 38, 39 . Although this classification is not precise, it is helpful in providing an overview of mutational signatures. Previously, NHEJ has been implicated in the reassembly of the DNA fragments generated by chromothripsis 2, 34 , whereas alternative end-joining (alt-EJ) has been proposed to occur in constitutional chromothripsis and in glioblastomas 15, 40 . In addition, short templated insertions suggestive of microhomology-mediated breakinduced replication (MMBIR) or alt-NHEJ associated with polymerase theta have been detected in chromothripsis originated from DNA fragmentation in micronuclei 2, [41] [42] [43] .
We analyzed the breakpoints involved in canonical chromothripsis events showing evidence of interspersed LOH, as most SVs in such cases are chromothripsis-related (Fig. 1b) . In 55% of these events, we only detected repair signatures concordant with NHEJ or alt-EJ ( Supplementary Fig. 6 ). In 32%, we identified stretches of microhomology at two or more breakpoint junctions (most of them of 0-6 bp) and short insertions of 10-500 bp that map to distant locations within the affected region by chromothripsis ( Supplementary Fig. 6 ). For instance, in the massive chromothripsis case depicted in Fig. 2a We also find features associated to replication-associated mechanisms in more complex rearrangements involving multiple chromosomes (Fig. 4) . In a number of these events, LOH is observed in some chromosomes (e.g., Fig. 4b ), but it is absent in others, where the oscillations occur at higher CN states without LOH (Fig. 4c,d ). For instance, in the case reported in Fig. 4 , there is evidence of templated insertions in chromosomes 5 and 13, which are linked to a chromothripsis event showing LOH in chromosome 1. Notably, the minor CN (i.e., the copy number of the allele with the lower number of copies) for the templated insertions in chromosome 13 is 1, whereas for the rest of the chromosome is 0. This suggests that one parental chromosome served as a template and was later lost to the cell.
Overall, these results hint at the involvement of template switching events in the generation or repair of complex rearrangements, consistent with the observations of replicative processes in the formation of clustered rearrangements in congenital disorders and cancer 15, 19, 38, 23, 44 . Although further experimental evidence will be necessary, we postulate that the involvement of replication-associated mechanisms in the assembly of derivative chromosomes in chromothripsis might be substantial.
Oncogene amplification in chromothripsis regions
Evidence of double minute (DM) formation from chromothripsis has been reported for selected cancer types 1, 2, 8, 40 . However, the extent to which chromothripsis contributes to DM formation has not been fully examined on a pan-cancer scale. Although reconstruction of DM structure with appropriate discordant reads would present clear evidence for its extrachromosomal nature, this proves to be too difficult in most cases.
Therefore, we rely on copy number to make our inferences. We find that 15 patients (2% of tumors with chromothripsis) show CN oscillations between one low (CN≤4) and one very high (CN≥10) states, consistent with the presence of DM 8, 40 . We detect known cancer drivers in these putative DMs, including MDM2 (4 samples, Supplementary Figs. 3e and 4a, and Supplementary Table 2) , and CDK4 (4). These amplifications lead to increased mRNA levels: e.g., 5 log2-fold increase for MDM2, NUP107, and CDK4 in a GBM sample (DO14049) compared to other GBM tumors. In chromothripsis regions subject to additional rearrangements, it is not always possible to discern using bulk sequencing data alone whether highly amplified segments are part of DMs or correspond to intrachromosomal gene amplification 45 . Furthermore, once a DM has formed, the derivative chromosome showing chromothripsis may be lost if it has no other tumor-promoting mutations. Therefore, the contribution of chromothripsis to the formation of extrachromosomal DNA bodies is likely to be higher than estimated here. . Except for few selected cancer types 5, 49 , the extent to which chromothripsis contributes to the loss of these genes has not been thoroughly examined yet. We find that chromothripsis underlies 2.1% and 1.9% of the losses of tumor suppressors and DNA repair genes, respectively. These include MLH1 (9 patients out of 301 harboring 
Chromothripsis is prognostic of poor patient survival
Chromothripsis has been associated with poor prognosis for several cancer types 5, 8, 9, 51 .
Here, the increased sensitivity of our approach and the larger cohort permits us to evaluate the impact of chromothripsis on patient survival in greater detail, and to determine the biological contexts in which chromothripsis leads to more aggressive ; Supplementary Fig. 8a ).
The HR for the samples in the predominant and moderate chromothripsis categories are Supplementary Fig. 8b ).
DISCUSSION
Our analysis of ca. 2,600 cancer genomes has revealed that chromothripsis plays a major role in shaping the architecture of cancer genomes across diverse human cancers, with prevalence and heterogeneity much higher than previously appreciated and marked variability across cancer types. Our approach enabled us to define more nuanced criteria to detect chromothripsis events, including those that involve multiple chromosomes and those that were hard to detect previously due to the presence of other co-localized rearrangements.
We note that the estimated frequencies of chromothripsis depend on the cut-off values used for statistical significance. We have tested various parameters and chose conservative thresholds, such as at least 7 CN segments oscillating between two copy number states for the high-confidence calls; however, we cannot exclude the possibility that some of these chromothripsis-like patterns might have arisen due to other sources of genomic instability. Conversely, it is also possible that we missed true chromothripsis events that have fewer than the required number of rearrangements; it is worth noting that such small-scale events are seen in experimentally generated chromothripsis 2 .
Cases in which chromothripsis is followed by other complex rearrangements that mask the canonical CN pattern are especially difficult to detect, requiring additional criteria and in-depth manual inspection. Despite these limitations, we believe that our statistical approach based on observed frequencies of various alterations compared to the background is more sensitive than a reassembly-based approach. The latter method attempts to reconstruct the steps that led to the observed SV pattern, but most complex events are too complicated, especially when many breakpoints are entirely missed and some are incorrectly identified due to inherent limitation of short-read data, imperfect SV algorithms, and insufficient sequencing coverage.
A substantial fraction of the chromothripsis events we detect show templated insertions and evidence of MMBIR. Although chromothripsis and chromoanasynthesis are considered to be two different processes, they often lead to similar SV and CN profiles, especially when occurring in aneuploid genomes, as oscillating CN profiles with interspersed LOH might be generated by replicative processes alone if the DNA polymerase skips over segments of the template. Moreover, there is experimental evidence that MMBIR and NHEJ can co-exist in chromothripsis induced in micronuclei 2 .
Therefore, further experiments will be required to assess the interplay between DNA repair mechanisms in chromothripsis.
Given the pervasiveness of chromothripsis in human cancers and its association with poorer prognosis, another question that arises is whether chromothripsis per se constitutes an actionable molecular event amenable to therapy. This is particularly interesting given the link between aneuploidy, depleted immune infiltration, and reduced response to immunotherapy 52 . As more WGS data are linked to other data types including clinical information, it will become more feasible to understand the impact of chromothripsis on tumorigenesis and its potential as a biomarker for diagnosis or treatment.
Online Methods
Whole-genome sequencing data
We integrated in a common processing pipeline whole-genome sequencing data from the TCGA and ICGC consortia for 2,658 tumor and matched normal pairs across 39 cancer types, of which 2,543 pairs spanning 37 cancer types that passed our qualitycontrol criteria were selected for further analysis 53 . . Sequencing reads were aligned using BWA-MEM 0.7.8-r455, whereas biobambam 0.0.138 was used to extract unpaired reads and mark duplicates 55, 56 .
Mutation calling
We utilized the consensus SNV and indel calls sets released by the Pan-Cancer
Analysis of Whole Genomes (PCAWG) project, whereas we used HaplotypeCaller 3.4-46-gbc0262554 to call single nucleotide polymorphisms (SNPs) in both tumor and matched normal samples following the GATK best practices guidelines. We only kept
SNPs supported by at least 10 reads. We processed a total of 210,021 non-synonymous somatic mutations, of which 43,548 were predicted as deleterious using the MetaLR score as implemented in Annovar
57
. To identify APOBEC mutagenesis we followed the procedure previously described 33 . In brief, we considered as APOBEC-associated mutations those involving a change of (i) G within the sequence motif wGa to a C or A (where w is A or T), and (ii) C in the sequence motif tCw to G or T (where w is A or T).
Detection of SVs and SCNAs
The SVs were identified by the ICGC SV subgroup, which applied four algorithms and selected those SVs found by at least two algorithms 23, 54 . We used the consensus SV, SCNA, purity and ploidy call sets generated by the PCAWG project. The calling pipelines 
RNA-seq data analysis
We processed RNA-seq data for a total of 162 and 1,268 normal and tumor samples, respectively. Sequencing reads were aligned using Top H a t2 a nd STA R 58,59
. , whereas the set of tumor suppressors was downloaded from TSGene 2.0, COSMIC (recessive genes) and 62, 63 . DNA repair genes were extracted from 64 .
Characterization of chromothripsis events using ShatterSeek
To identify and visualize chromothripsis-like patterns in the cancer genomes using CN and SV data, we extended the set of statistical criteria proposed by 3 Duplication-like SVs, deletion-like SVs, head-to-head and tail-to-tail inversions are depicted in blue, orange, black, and green, respectively. The value for the statistical criteria described above for each event is provided below its representation.
Survival analysis
We performed multivariate analysis using the Cox proportional hazards model corrected 
Data availability
The code for calling chromothripsis events is available at https://github.com/parklab/ShatterSeek.
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